{"id":"W4317105117","doi":"10.1093/ehjcvp/pvad006","title":"Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial","year":2023,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences","funders":"Janssen Pharmaceuticals; Abbott Vascular; CytoSorbents Europe; MicroPort; Idorsia Pharmaceuticals; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; PharmaMar; Eisai; Sanofi; Abiomed; Amarin Pharma; Novo Nordisk; AtriCure; Daiichi-Sankyo; Medicines Company; AstraZeneca; Amarin Corporation; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Daiichi Sankyo Europe; Gilead Sciences; Amgen; Pfizer; Boston Scientific Corporation; National Science Foundation","keywords":"Ticagrelor; Medicine; Aspirin; Percutaneous coronary intervention; Internal medicine; Hazard ratio; Conventional PCI; Myocardial infarction; Clinical endpoint; Placebo; Stroke (engine); Cardiology; Randomized controlled trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00210322,0.0003990363,0.001367316,0.0006207122,0.000263273,0.00006908434,0.000308843,0.00006138871,0.0002698933],"category_scores_gemma":[0.00004609598,0.0002205575,0.003127645,0.002562405,0.0001964817,0.0001786962,0.00005796055,0.0006781038,0.00002348932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001367326,"about_ca_system_score_gemma":0.0001956372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004391168,"about_ca_topic_score_gemma":0.00004097593,"domain_scores_codex":[0.9945723,0.00222118,0.0007248126,0.000514182,0.001488975,0.0004785516],"domain_scores_gemma":[0.9982459,0.000132814,0.0002828971,0.0008314224,0.0002486491,0.0002583218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09374072,0.0008246464,0.771446,0.0001417272,0.07967034,0.00442814,0.0006657717,0.01419965,0.000252677,0.000002143115,0.000238764,0.03438936],"study_design_scores_gemma":[0.1299901,0.003302122,0.8368505,0.0007631472,0.01681032,0.002225579,0.0003299033,0.0004368928,0.0003232219,0.00000377819,0.008457263,0.0005072104],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946839,0.003029057,0.000562562,0.00008490394,0.0002742076,0.001154529,0.00002803369,0.00008277449,0.00009999028],"genre_scores_gemma":[0.9955662,0.003256209,0.0002005706,0.0002636846,0.0003400988,0.0000130039,0.00003745198,0.0001297937,0.0001929637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0654044,"threshold_uncertainty_score":0.8994074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01962897758834716,"score_gpt":0.2786518573281694,"score_spread":0.2590228797398222,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}